CEBPB and colorectal cancer: Here, we used integrated transcriptomic analyses of healthy and colorectal cancer samples from three datasets—TCGA-COAD, GSE100179 and GSE196006, and laboratory assays to uncover CCAAT/enhancer-binding protein beta (CEBPB) as a key driver of CRC.